Results 181 to 190 of about 24,471 (215)

Meningococcal tetravalent conjugate vaccine

Expert Opinion on Biological Therapy, 2008
Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. Since 1981, a tetravalent meningococcal polysaccharide vaccine has been available in the US but it has been limited to high-risk patients and outbreak settings. In 2005, a tetravalent polysaccharide meningococcal conjugate vaccine (MCV4) was licensed for routine use in the US.
openaire   +2 more sources

Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers

New England Journal of Medicine, 2021
Milagritos D Tapia, Amol Chaudhari, Ray Borrow   +2 more
exaly  

Meningococcal group A, C, Y and W-135 conjugate vaccine

Nature Reviews Drug Discovery, 2010
Peter Kirkpatrick, Lee H Harrison
exaly  

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

Lancet, The, 2014
Robert C Read, Saul N Faust, Adam Finn
exaly  

Meningococcal vaccines

Inpharma Weekly, 1998
openaire   +2 more sources

Meningococcal conjugate vaccines: new opportunities and new challenges

Lancet, The, 1999
Martin C J Maiden, Brian G Spratt
exaly  

Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020

MMWR Recommendations and Reports, 2020
Jonathan Duffy
exaly  

Meningococcal Vaccine

2014
Pooja Dewan, MMA Faridi
openaire   +2 more sources

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

Lancet, The, 2001
Nick Andrews, Elizabeth Miller
exaly  

Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study

Lancet, The, 2017
Helen A Petousis-Harris, Janine Paynter, Felicity Goodyear-Smith   +2 more
exaly